Moneycontrol PRO
HomeNewsBusinessMarketsHospital sector likely to firm up on higher occupancy, favourable base in Q4

Hospital sector likely to firm up on higher occupancy, favourable base in Q4

Most brokerages anticipate that the trend of capacity expansion will persist throughout the sector. Investor attention will remain focused on management commentaries for insights into plans to expand capacity, as well as the potential impact of this on profitability and margins.

April 20, 2023 / 06:39 IST
Representative Image

The hospital sector is widely expected to post strong growth numbers for the January-March quarter, aided by better bed occupancy and a favourable base effect.

Typically, the festive season from October to December results in lower occupancy rates and a seasonally weak performance for hospital companies in the third quarter. Accordingly, several brokerages anticipate improved bed occupancy rates for hospitals in the fourth quarter.

Looking beyond the pandemic

Brokerage firm ICICIdirect expects hospitals to report normalised earnings in the fourth quarter as Covid pandemic-related positives and negatives, as well as festive season weakness, become less relevant in the January-March period. The firm believes that hospitals will benefit from positive structural tailwinds, including a better case and payer mix, improved occupancy, higher average revenue per occupied bed (ARPOB), and reduced length of stay, all of which will contribute to their improved performance in Q4.

According to global research and broking firm Jefferies, growth for Max Healthcare, Apollo Hospitals and Fortis Healthcare will be driven by an increase in occupancy, while Global Health (operator of Medanta hospital chains) will benefit from a ramp-up in Lucknow/Patna hospitals.

On top of that, Jefferies also believes Apollo Hospitals could benefit from lower losses in its HealthCo division, as revenues continue to ramp up while investments peak out.

Talking about Fortis Healthcare, Nuvama Institutional Equities anticipates that the healthcare services company's hospital business will remain upbeat, with expectations of 26 percent on-year revenue growth, led by improved occupancy and steady ARPOBs. As a result, Nuvama sees steady margins for Fortis at around 17 percent in Q4. As for the company’s diagnostics business, SRL Diagnostics is likely to remain subdued due to competitive pressures and post 11 percent on-year growth on a low base, but remain flat sequentially, the brokerage said.

Positive outlook

In addition, ICICIdirect also holds a positive outlook on the hospital industry, beyond the fourth-quarter earnings. The firm believes that the sector remains stable due to factors such as a profitable payer mix, favourable case mix, increased adoption of telemedicine, digital apps for remote treatment, and an expanding range of home-care services.

Meanwhile, most brokerages anticipate that the trend of capacity expansion will persist throughout the sector. As a result, investor attention will remain focused on management commentaries that provide insights into plans to expand capacity, as well as the potential impact of this on profitability and margins.

Disclaimer: The views and investment tips expressed by experts on Moneycontrol are their own and not those of the website or its management. Moneycontrol advises users to check with certified experts before taking any investment decisions.

Vaibhavi Ranjan
first published: Apr 19, 2023 04:58 pm

Discover the latest Business News, Sensex, and Nifty updates. Obtain Personal Finance insights, tax queries, and expert opinions on Moneycontrol or download the Moneycontrol App to stay updated!

Subscribe to Tech Newsletters

  • On Saturdays

    Find the best of Al News in one place, specially curated for you every weekend.

  • Daily-Weekdays

    Stay on top of the latest tech trends and biggest startup news.

Advisory Alert: It has come to our attention that certain individuals are representing themselves as affiliates of Moneycontrol and soliciting funds on the false promise of assured returns on their investments. We wish to reiterate that Moneycontrol does not solicit funds from investors and neither does it promise any assured returns. In case you are approached by anyone making such claims, please write to us at grievanceofficer@nw18.com or call on 02268882347